Van ECK Associates Corp Buys 139,404 Shares of GE HealthCare Technologies Inc. $GEHC

Van ECK Associates Corp increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 3.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,497,827 shares of the company’s stock after purchasing an additional 139,404 shares during the quarter. Van ECK Associates Corp’s holdings in GE HealthCare Technologies were worth $337,787,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in GE HealthCare Technologies by 1.4% in the second quarter. Vanguard Group Inc. now owns 52,107,758 shares of the company’s stock worth $3,859,622,000 after purchasing an additional 703,903 shares in the last quarter. Capital Research Global Investors raised its holdings in shares of GE HealthCare Technologies by 25.0% in the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after buying an additional 4,998,154 shares during the last quarter. Dodge & Cox raised its holdings in shares of GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after buying an additional 6,982,441 shares during the last quarter. State Street Corp grew its holdings in GE HealthCare Technologies by 1.9% during the 2nd quarter. State Street Corp now owns 19,660,742 shares of the company’s stock worth $1,456,271,000 after acquiring an additional 372,755 shares during the last quarter. Finally, Geode Capital Management LLC increased its position in GE HealthCare Technologies by 2.0% in the 2nd quarter. Geode Capital Management LLC now owns 11,944,407 shares of the company’s stock valued at $881,060,000 after acquiring an additional 231,302 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $75.63 on Tuesday. The firm has a fifty day moving average of $81.66 and a two-hundred day moving average of $78.62. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The stock has a market capitalization of $34.47 billion, a price-to-earnings ratio of 16.59, a PEG ratio of 1.63 and a beta of 1.03. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. During the same period last year, the company earned $1.45 EPS. The firm’s revenue was up 7.1% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Wall Street Analyst Weigh In

GEHC has been the subject of a number of research analyst reports. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $98.00 target price on shares of GE HealthCare Technologies in a research note on Friday, January 9th. Jefferies Financial Group upped their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a report on Thursday, December 11th. Stifel Nicolaus increased their price objective on GE HealthCare Technologies from $95.00 to $98.00 and gave the company a “buy” rating in a research report on Wednesday, February 4th. Barclays boosted their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Finally, BTIG Research raised their price target on GE HealthCare Technologies from $87.00 to $91.00 and gave the company a “buy” rating in a report on Wednesday, February 4th. Seven research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.